Figure 1.
Figure 1. Long-term outcomes after aggressive therapy. (A) Failure-free survival (FFS) of FL patients treated with frontline chemotherapy regimens at MD Anderson Cancer Center.10 Most regimens resulted in a plateau of FFS curves between 8 and 10 years. Data adapted. (B) Long-term follow-up of patients (N = 121) who received cyclophosphamide and total-body irradiation followed by autologous bone marrow transplantation compared with matched control group.19 Data adapted. (C) Long-term follow-up of FL patients (N = 47) treated with nonmyeloablative allogeneic transplantation.20 Data adapted.

Long-term outcomes after aggressive therapy. (A) Failure-free survival (FFS) of FL patients treated with frontline chemotherapy regimens at MD Anderson Cancer Center.10  Most regimens resulted in a plateau of FFS curves between 8 and 10 years. Data adapted. (B) Long-term follow-up of patients (N = 121) who received cyclophosphamide and total-body irradiation followed by autologous bone marrow transplantation compared with matched control group.19  Data adapted. (C) Long-term follow-up of FL patients (N = 47) treated with nonmyeloablative allogeneic transplantation.20  Data adapted.

Close Modal

or Create an Account

Close Modal
Close Modal